ArticleReproductive biomedicine & society online2016
The birth and routinization of IVF in China.
Article in Reproductive biomedicine & society online, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Between Exclusion and Legitimacy: Identity Negotiation and Ethical Dilemmas of Chinese Lesbians in the Assisted Reproduction System.Developing world bioethics · 2026Article
- NovelThe world journal of men's health · 2022Review
- Perceptions and attitudes towards elective egg freezing of Chinese college students: a survey from eastern China.Journal of assisted reproduction and genetics · 2022Article
- Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies.BioSocieties · 2022Article
- Maternal gestational diabetes in singleton pregnancies conceived by ART may be modified by periconceptional B vitamins.Frontiers in nutrition · 2022Article
- Preterm births in China between 2012 and 2018: an observational study of more than 9 million women.The Lancet. Global health · 2021Observational
- 'You are not Young Anymore!': Gender, Age and the Politics of Reproduction in Post-reform China.Asian bioethics review · 2021Article
- IVF and other ART in low- and middle-income countries: a systematic landscape analysis.Human reproduction update · 2021Review
- Excessive gestational weight gain in the first and second trimester is a risk factor for gestational diabetes mellitus among women pregnant with singletons: A repeated measures analysis.Journal of diabetes investigation · 2020Article
- Assessment of the development of assisted reproductive technology in Liaoning province of China, from 2012 to 2016.BMC health services research · 2018Article
- Attitudes Towards the Donation of Human Embryos for Stem Cell Research Among Chinese IVF Patients and Students.Journal of bioethical inquiry · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
How can it be that China, with its history of restrictive family planning policies, is today home to some of the world's largest IVF clinics, carrying out as many as 30,000 cycles annually? This article addresses how IVF was developed in China during the early 1980s, becoming routinized at the same time as one of the world's most comprehensive family planning programmes aimed at preventing birth was being rolled out. IVF was not merely imported into China; rather it was experimentally developed within China into a form suitable for its restrictive family planning regulations. As a result, IVF and other procedures of assisted reproductive technology have settled alongside contraception, sterilization and abortion as yet another technology of birth control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.